PD-L1 expression in perihilar and intrahepatic cholangiocarcinoma

Cholangiocarcinoma is an aggressive biliary neoplasm lacking effective therapeutic agents. Immunotherapies targeting the PD-L1/PD-1 immune checkpoint have shown encouraging results in solid and hematologic cancers in clinical trials. Response to these immunomodulators is correlated with PD-L1 expres...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Oncotarget
Main Authors: Fontugne, Jacqueline, Augustin, Jérémy, Pujals, Anaïs, Compagnon, Philippe, Rousseau, Benoit, Luciani, Alain, Tournigand, Christophe, Cherqui, Daniel, Azoulay, Daniel, Pawlotsky, Jean-Michel, Calderaro, Julien
Formato: Artigo
Idioma:Inglês
Publicado: Impact Journals LLC 2017
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5421876/
https://ncbi.nlm.nih.gov/pubmed/28445951
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.15602
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares